Hauptseite > Workflowsammlungen > In Bearbeitung > Sleep disturbances and Alzheimer’s disease: a multiscale approach from exposome to neurobiology and precision medicine > print

001     1055237
005     20260303093843.0
024 7 _ |a 10.1007/s11357-026-02152-8
|2 doi
024 7 _ |a 2509-2715
|2 ISSN
024 7 _ |a 0161-9152
|2 ISSN
024 7 _ |a 1574-4647
|2 ISSN
024 7 _ |a 2152-4041
|2 ISSN
024 7 _ |a 2331-3765
|2 ISSN
024 7 _ |a 2331-3773
|2 ISSN
024 7 _ |a 2452-0756
|2 ISSN
024 7 _ |a 2509-2723
|2 ISSN
037 _ _ |a FZJ-2026-01880
082 _ _ |a 610
100 1 _ |a Tahmasian, Masoud
|0 P:(DE-Juel1)188400
|b 0
|e Corresponding author
245 _ _ |a Sleep disturbances and Alzheimer’s disease: a multiscale approach from exposome to neurobiology and precision medicine
260 _ _ |a [Cham]
|c 2026
|b Springer International Publishing
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1772526966_12470
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Sleep disturbances and Alzheimer's disease (AD) are interconnected public health challenges. However, the underlying mechanisms of their complex relationships remain elusive. Here, we propose a hypothetical integrative, stream-like model outlining how external and internal exposome factors accelerate brain aging, thereby exacerbating circadian dysregulation, orexin-mediated hyperexcitability, metabolic imbalance, and inflammaging. These changes can lead to increased sleep fragmentation and reduced slow-wave sleep, triggering widespread neuroinflammation, glymphatic dysfunction, and the accumulation and dissemination of beta-amyloid and tau peptides. These processes collectively accelerate synaptic dysfunction, neuronal loss, and cognitive decline. We also highlight recent neuroimaging evidence that elucidates the neural substrates underlying the relationship between poor sleep and AD. Moreover, tackling their shared burden necessitates the active consideration of inter-individual variability in vulnerable populations through artificial intelligence and computational approaches, aligning with the core tenets of precision medicine. We hope this review encourages clinicians to prioritize monitoring and treating sleep disturbances to reduce the incidence, severity, and consequences of dementia in the general population.
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 0
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Elberse, Jorik D.
|0 P:(DE-Juel1)190450
|b 1
|u fzj
700 1 _ |a Ahmadi, Reihaneh
|b 2
700 1 _ |a Liu, Wen
|0 P:(DE-Juel1)201592
|b 3
|u fzj
700 1 _ |a Rosenzweig, Ivana
|b 4
700 1 _ |a Genon, Sarah
|0 P:(DE-Juel1)161225
|b 5
|u fzj
700 1 _ |a Eickhoff, Simon B.
|0 P:(DE-Juel1)131678
|b 6
|u fzj
700 1 _ |a Mander, Bryce A.
|b 7
773 _ _ |a 10.1007/s11357-026-02152-8
|0 PERI:(DE-600)2886418-9
|p -
|t GeroScience
|v -
|y 2026
|x 2509-2715
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)188400
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)190450
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)201592
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)161225
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)131678
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 1
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GEROSCIENCE : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-06
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-06
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-06
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b GEROSCIENCE : 2022
|d 2025-01-06
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-Juel1)INM-7-20090406
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21